search
PAIA Titer
Trends
- 1Nova Biomedical launches PAIA Titer for cell line development●Nova Biomedical introduces PAIA Titer technology for earlier cell line development insights
Nova Biomedical has introduced PAIA Titer technology, a new analytical tool designed to deliver titer measurements earlier in the cell line development process. The company says the technology gives biopharmaceutical developers faster insights during early screening stages, potentially shortening timelines for selecting high-producing cell lines in biologic drug development.